Skip to main content
SpringerLink
Log in

Promoting Cardiovascular Health in Men

  • Chapter
  • First Online:
Men's Health in Primary Care

Part of the book series: Current Clinical Practice ((CCP))

  • 1008 Accesses

Abstract

Heart disease remains the leading cause of death in the United States (USA) and the leading cause of mortality in men, killing 307,384 men in 2010. Although the age-adjusted heart disease death rate decreased 30 % from 257.6 to 179.1 deaths per 100,000 population between 2000 and 2010, heart disease still accounts for approximately 1 in 4 deaths among males [1]. Heart disease is the leading cause of mortality for men across most racial/ethnic groups in the USA, including African Americans, American Indians or Alaska Natives, Hispanics, and whites. For Asian American or Pacific Islander men, heart disease is second only to cancer as the leading cause of mortality [2]. About 8.5 % of all white men, 7.9 % of black men, and 6.3 % of Mexican American men have coronary heart disease. Half of the men who die suddenly of coronary heart disease have no previous symptoms. It is thought that between 70 % and 89 % of sudden cardiac events occur in men [3]. High blood pressure, low-density lipoprotein (LDL) cholesterol, diabetes mellitus, and smoking are key risk factors for heart disease. About half of Americans (49 %) have at least one of these three risk factors [4].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Holmes JS, Arise IE. Health, United States, 2013. With special feature on prescription drugs; 2013. http://www.cdc.gov/nchs/data/hus/hus13.pdf#024.

  2. Heron M. Deaths: leading causes for 2008. Natl Vital Stat Rep. 2012;60(6):1–94.

    PubMed  Google Scholar 

  3. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics–2012 update: a report from the American Heart Association. Circulation. 2012;125(1):e2–e220.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Ritchey MD, Wall HK, Gillespie C, George MG, Jamal A, Division for Heart Disease and Stroke Prevention, CDC. Million hearts: prevalence of leading cardiovascular disease risk factors–United States, 2005–2012. MMWR Morb Mortal Wkly Rep. 2014;63(21):462–7.

    PubMed  Google Scholar 

  5. Berry JD, Dyer A, Cai X, Garside DB, Ning H, Thomas A, et al. Lifetime risks of cardiovascular disease. N Engl J Med. 2012;366(4):321–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Goff Jr DC, Lloyd-Jones DM, Bennett G, Coady S, D’Agostino Sr RB, Gibbons R, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(25 Pt B):2935–59.

    Article  PubMed  Google Scholar 

  7. de la Iglesia R, Lopez-Legarrea P, Abete I, Bondia-Pons I, Navas-Carretero S, Forga L, et al. A new dietary strategy for long-term treatment of the metabolic syndrome is compared with the American Heart Association (AHA) guidelines: the MEtabolic Syndrome REduction in NAvarra (RESMENA) project. Br J Nutr. 2014;111(4):643–52.

    Article  PubMed  CAS  Google Scholar 

  8. Rees K, Hartley L, Flowers N, Clarke A, Hooper L, Thorogood M, et al. ‘Mediterranean’ dietary pattern for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013;8, CD009825.

    PubMed  Google Scholar 

  9. Leblanc V, Begin C, Hudon AM, Royer MM, Corneau L, Dodin S, et al. Gender differences in the long-term effects of a nutritional intervention program promoting the Mediterranean diet: changes in dietary intakes, eating behaviors, anthropometric and metabolic variables. Nutr J. 2014;13:107.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. Abete I, Romaguera D, Vieira AR, Lopez de Munain A, Norat T. Association between total, processed, red and white meat consumption and all-cause, CVD and IHD mortality: a meta-analysis of cohort studies. Br J Nutr. 2014;112(5):762–75.

    Article  PubMed  CAS  Google Scholar 

  11. Micha R, Wallace SK, Mozaffarian D. Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus: a systematic review and meta-analysis. Circulation. 2010;121(21):2271–83.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Micha R, Michas G, Mozaffarian D. Unprocessed red and processed meats and risk of coronary artery disease and type 2 diabetes–an updated review of the evidence. Curr Atheroscler Rep. 2012;14(6):515–24.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  13. Mozaffarian D, Fahimi S, Singh GM, Micha R, Khatibzadeh S, Engell RE, et al. Global sodium consumption and death from cardiovascular causes. N Engl J Med. 2014;371(7):624–34.

    Article  PubMed  Google Scholar 

  14. Moyer VA, U.S. Preventive Services Task Force. Vitamin, mineral, and multivitamin supplements for the primary prevention of cardiovascular disease and cancer: U.S. Preventive services Task Force recommendation statement. Ann Intern Med. 2014;160(8):558–64.

    Article  PubMed  Google Scholar 

  15. Schmidt M, Johannesdottir SA, Lemeshow S, Lash TL, Ulrichsen SP, Botker HE, et al. Obesity in young men, and individual and combined risks of type 2 diabetes, cardiovascular morbidity and death before 55 years of age: a Danish 33-year follow-up study. BMJ Open. 2013;3(4). doi: 10.1136/bmjopen-2013-002698. Print 2013.

    Google Scholar 

  16. Bogers RP, Bemelmans WJ, Hoogenveen RT, Boshuizen HC, Woodward M, Knekt P, et al. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons. Arch Intern Med. 2007;167(16):1720–8.

    Article  PubMed  Google Scholar 

  17. Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions? a systematic review and meta-analysis. Ann Intern Med. 2013;159(11):758–69.

    Article  PubMed  Google Scholar 

  18. Thomsen M, Nordestgaard BG. Myocardial infarction and ischemic heart disease in overweight and obesity with and without metabolic syndrome. JAMA Intern Med. 2014;174(1):15–22.

    Article  PubMed  CAS  Google Scholar 

  19. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol. 2014;63(25 Pt B):2985–3023.

    Article  PubMed  Google Scholar 

  20. Robertson C, Archibald D, Avenell A, Douglas F, Hoddinott P, van Teijlingen E, et al. Systematic reviews of and integrated report on the quantitative, qualitative and economic evidence base for the management of obesity in men. Health Technol Assess. 2014;18(35):v–vi, xxiii–xxix, 1–424.

    Google Scholar 

  21. Franco OH, de Laet C, Peeters A, Jonker J, Mackenbach J, Nusselder W. Effects of physical activity on life expectancy with cardiovascular disease. Arch Intern Med. 2005;165(20):2355–60.

    Article  PubMed  Google Scholar 

  22. Leitzmann MF, Park Y, Blair A, Ballard-Barbash R, Mouw T, Hollenbeck AR, et al. Physical activity recommendations and decreased risk of mortality. Arch Intern Med. 2007;167(22):2453–60.

    Article  PubMed  Google Scholar 

  23. Peters SA, Huxley RR, Woodward M. Smoking as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 81 cohorts, including 3,980,359 individuals and 42,401 strokes. Stroke. 2013;44(10):2821–8.

    Article  PubMed  Google Scholar 

  24. Huxley RR, Woodward M. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet. 2011;378(9799):1297–305.

    Article  PubMed  Google Scholar 

  25. Mons U, Muezzinler A, Gellert C, Schottker B, Abnet CC, Bobak M, et al. Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium. BMJ. 2015;350:h1551.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Stead LF, Lancaster T. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev. 2012;10, CD008286.

    PubMed  Google Scholar 

  27. Suls JM, Luger TM, Curry SJ, Mermelstein RJ, Sporer AK, An LC. Efficacy of smoking-cessation interventions for young adults: a meta-analysis. Am J Prev Med. 2012;42(6):655–62.

    Article  PubMed  PubMed Central  Google Scholar 

  28. US Preventive Services Task Force. Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;150(6):396–404.

    Google Scholar 

  29. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560–72.

    Article  PubMed  CAS  Google Scholar 

  30. Ogden LG, He J, Lydick E, Whelton PK. Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. Hypertension. 2000;35(2):539–43.

    Article  PubMed  CAS  Google Scholar 

  31. Heidelbaugh JJ, Tortorello M. The adult well male examination. Am Fam Physician. 2012;85(10):964–71.

    PubMed  Google Scholar 

  32. Piper MA, Evans CV, Burda BU, Margolis KL, O’Connor E, Smith N, et al. Screening for high blood pressure in adults: a systematic evidence review for the U.S. Preventive Services Task Force; 2014 Dec.

    Google Scholar 

  33. U.S. Preventive Services Task Force. Screening for high blood pressure: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2007;147(11):783–6.

    Google Scholar 

  34. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–20.

    Article  PubMed  CAS  Google Scholar 

  35. National High Blood Pressure Education Program. The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure; 2004 Aug.

    Google Scholar 

  36. Daugherty SL, Masoudi FA, Ellis JL, Ho PM, Schmittdiel JA, Tavel HM, et al. Age-dependent gender differences in hypertension management. J Hypertens. 2011;29(5):1005–11.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  37. Wilkins K, Gee M, Campbell N. The difference in hypertension control between older men and women. Health Rep. 2012;23(4):33–40.

    PubMed  Google Scholar 

  38. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics–2013 update: a report from the American Heart Association. Circulation. 2013;127(1):e6–e245.

    Article  PubMed  Google Scholar 

  39. DECODE Study Group. Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care. 2003;26(1):61–9.

    Article  Google Scholar 

  40. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21(9):1414–31.

    Article  PubMed  CAS  Google Scholar 

  41. Schipf S, Werner A, Tamayo T, Holle R, Schunk M, Maier W, et al. Regional differences in the prevalence of known Type 2 diabetes mellitus in 45–74 years old individuals: results from six population-based studies in Germany (DIAB-CORE Consortium). Diabet Med. 2012;29(7):e88–95.

    Article  PubMed  CAS  Google Scholar 

  42. Pan C, Yang W, Jia W, Weng J, Tian H. Management of Chinese patients with type 2 diabetes, 1998–2006: the Diabcare-China surveys. Curr Med Res Opin. 2009;25(1):39–45.

    Article  PubMed  Google Scholar 

  43. Inoue M, Inoue K, Akimoto K. Effects of age and sex in the diagnosis of type 2 diabetes using glycated haemoglobin in Japan: the Yuport Medical Checkup Centre study. PLoS One. 2012;7(7), e40375.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  44. Lin CC, Li CI, Hsiao CY, Liu CS, Yang SY, Lee CC, et al. Time trend analysis of the prevalence and incidence of diagnosed type 2 diabetes among adults in Taiwan from 2000 to 2007: a population-based study. BMC Public Health. 2013;13:318.

    Article  PubMed  PubMed Central  Google Scholar 

  45. American Diabetes Association. (6) Glycemic targets. Diabetes Care. 2015;38(Suppl):S33–40.

    Google Scholar 

  46. Standards of medical care in diabetes–2015: summary of revisions. Diabetes Care. 2015;38(Suppl):S4–S003.

    Google Scholar 

  47. Haas L, Maryniuk M, Beck J, Cox CE, Duker P, Edwards L, et al. National standards for diabetes self-management education and support. Diabetes Care. 2014;37 Suppl 1:S144–53.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Sulkin TV, Bosman D, Krentz AJ. Contraindications to metformin therapy in patients with NIDDM. Diabetes Care. 1997;20(6):925–8.

    Article  PubMed  CAS  Google Scholar 

  49. Salpeter SR, Greyber E, Pasternak GA, Salpeter Posthumous EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev. 2010;(1):CD002967. doi(1):CD002967.

    Google Scholar 

  50. Blonde L, Dailey GE, Jabbour SA, Reasner CA, Mills DJ. Gastrointestinal tolerability of extended-release metformin tablets compared to immediate-release metformin tablets: results of a retrospective cohort study. Curr Med Res Opin. 2004;20(4):565–72.

    Article  PubMed  CAS  Google Scholar 

  51. Hermann LS. Metformin: a review of its pharmacological properties and therapeutic use. Diabete Metab. 1979;5(3):233–45.

    PubMed  CAS  Google Scholar 

  52. Cusi K, DeFronzo RA. Metformin: a review of its metabolic effects. Diabetes Rev. 1998;6:89–131.

    Google Scholar 

  53. Bennett WL, Maruthur NM, Singh S, Segal JB, Wilson LM, Chatterjee R, et al. Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations. Ann Intern Med. 2011;154(9):602–13.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006;114(7):e257–354.

    Article  PubMed  Google Scholar 

  55. Amerena JV, Walters TE, Mirzaee S, Kalman JM. Update on the management of atrial fibrillation. Med J Aust. 2013;199(9):592–7.

    Article  PubMed  Google Scholar 

  56. Wann LS, Curtis AB, January CT, Ellenbogen KA, Lowe JE, Estes NA, 3rd, et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;123(1):104–23.

    Google Scholar 

  57. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland Jr JC, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64(21):e1–76.

    Article  PubMed  Google Scholar 

  58. Ntaios G, Lip GY, Makaritsis K, Papavasileiou V, Vemmou A, Koroboki E, et al. CHADS(2), CHA(2)S(2)DS(2)-VASc, and long-term stroke outcome in patients without atrial fibrillation. Neurology. 2013;80(11):1009–17.

    Article  PubMed  CAS  Google Scholar 

  59. Cholesterol Treatment Trialists’ (CTT) Collaboration, Fulcher J, O’Connell R, Voysey M, Emberson J, Blackwell L, et al. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. Lancet. 2015;385(9976):1397–405.

    Article  CAS  Google Scholar 

  60. Taylor F, Huffman MD, Macedo AF, Moore TH, Burke M, Davey Smith G, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013;1, CD004816.

    PubMed  Google Scholar 

  61. Kostis WJ, Cheng JQ, Dobrzynski JM, Cabrera J, Kostis JB. Meta-analysis of statin effects in women versus men. J Am Coll Cardiol. 2012;59(6):572–82.

    Article  PubMed  CAS  Google Scholar 

  62. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(25 Pt B):2889–934.

    Article  PubMed  Google Scholar 

  63. Johnson KM, Dowe DA. Accuracy of statin assignment using the 2013 AHA/ACC Cholesterol Guideline versus the 2001 NCEP ATP III guideline: correlation with atherosclerotic plaque imaging. J Am Coll Cardiol. 2014;64(9):910–9.

    Article  PubMed  Google Scholar 

  64. Pencina MJ, Navar-Boggan AM, D’Agostino Sr RB, Williams K, Neely B, Sniderman AD, et al. Application of new cholesterol guidelines to a population-based sample. N Engl J Med. 2014;370(15):1422–31.

    Article  PubMed  CAS  Google Scholar 

  65. Pursnani A, Mayrhofer T, Ferencik M, Hoffmann U. The 2013 ACC/AHA cardiovascular prevention guidelines improve alignment of statin therapy with coronary atherosclerosis as detected by coronary computed tomography angiography. Atherosclerosis. 2014;237(1):314–8.

    Article  PubMed  CAS  Google Scholar 

  66. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics–2015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29–322.

    Article  PubMed  Google Scholar 

  67. Muhlestein JB, Lappe DL, Lima JA, Rosen BD, May HT, Knight S, et al. Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial. JAMA. 2014;312(21):2234–43.

    Article  PubMed  CAS  Google Scholar 

  68. Goldstein LB, Bushnell CD, Adams RJ, Appel LJ, Braun LT, Chaturvedi S, et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(2):517–84.

    Article  PubMed  Google Scholar 

  69. Guirguis-Blake JM, Beil TL, Senger CA, Whitlock EP. Ultrasonography screening for abdominal aortic aneurysms: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2014;160(5):321–9.

    Article  PubMed  Google Scholar 

  70. Rooke TW, Hirsch AT, Misra S, Sidawy AN, Beckman JA, Findeiss L, et al. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61(14):1555–70.

    Article  PubMed  Google Scholar 

  71. Aggarwal S, Qamar A, Sharma V, Sharma A. Abdominal aortic aneurysm: a comprehensive review. Exp Clin Cardiol. 2011;16(1):11–5. Spring.

    PubMed  PubMed Central  Google Scholar 

  72. Keisler B, Carter C. Abdominal aortic aneurysm. Am Fam Physician. 2015;91(8):538–43.

    PubMed  Google Scholar 

  73. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol. 2006;47(6):1239–312.

    Article  PubMed  Google Scholar 

  74. Moyer VA, U.S. Preventive Services Task Force. Screening for coronary heart disease with electrocardiography: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157(7):512–8.

    PubMed  Google Scholar 

  75. Pflieger M, Winslow BT, Mills K, Dauber IM. Medical management of stable coronary artery disease. Am Fam Physician. 2011;83(7):819–26.

    PubMed  Google Scholar 

  76. Hall SL, Lorenc T. Secondary prevention of coronary artery disease. Am Fam Physician. 2010;81(3):289–96.

    PubMed  Google Scholar 

  77. Dehghan M, Mente A, Teo KK, Gao P, Sleight P, Dagenais G, et al. Relationship between healthy diet and risk of cardiovascular disease among patients on drug therapies for secondary prevention: a prospective cohort study of 31 546 high-risk individuals from 40 countries. Circulation. 2012;126(23):2705–12.

    Article  PubMed  CAS  Google Scholar 

  78. Davie AP, Francis CM, Caruana L, Sutherland GR, McMurray JJ. Assessing diagnosis in heart failure: which features are any use? QJM. 1997;90(5):335–9.

    Article  PubMed  CAS  Google Scholar 

  79. Dosh SA. Diagnosis of heart failure in adults. Am Fam Physician. 2004;70(11):2145–52.

    PubMed  Google Scholar 

  80. Kelder JC, Cramer MJ, van Wijngaarden J, van Tooren R, Mosterd A, Moons KG, et al. The diagnostic value of physical examination and additional testing in primary care patients with suspected heart failure. Circulation. 2011;124(25):2865–73.

    Article  PubMed  Google Scholar 

  81. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey Jr DE, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;128(16):e240–327. Writing Committee Members.

    Article  PubMed  Google Scholar 

  82. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123(8):933–44.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Family Medicine, University of Rochester—Highland Hospital, Rochester, NY, USA

    Michael Mendoza MD, MPH, MS & Colleen Loo-Gross MD, MPH

  2. Department Public Health Sciences, University of Rochester—Highland Hospital, Rochester, NY, USA

    Michael Mendoza MD, MPH, MS

Authors
  1. Michael Mendoza MD, MPH, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Colleen Loo-Gross MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Mendoza MD, MPH, MS .

Editor information

Editors and Affiliations

  1. Depts. of Family Medicine and Urolo, University of Michigan Medical Scho, Ann Arbor, New York, USA

    Joel J. Heidelbaugh

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Mendoza, M., Loo-Gross, C. (2016). Promoting Cardiovascular Health in Men. In: Heidelbaugh, J. (eds) Men's Health in Primary Care. Current Clinical Practice. Humana Press, Cham. https://doi.org/10.1007/978-3-319-26091-4_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-26091-4_8

  • Published:

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-26089-1

  • Online ISBN: 978-3-319-26091-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation